BioAge Labs, Inc. BIOA

Set alert

Price alert · BIOA

All alert types
5.85 USD +0.05 +0.86%

As of Nov 3, 2:53 PM ET

Bid
5.85 × 2
Ask
5.87 × 2
5.58 Day range 6.01
4.81 52-week range 25.96
YTD
-55.78%
1 year
-21.16%
Open
5.83
Prev close
5.80
Mkt cap
269.19M
Vol
586.31K
Avg vol
776.57K
EPS
-2.39
P/E
0.00
Div yield
0.00%
More statistics
Low
5.58
High
6.01
Forward P/E
-12.08
Beta
0.00
Short ratio
4.63
Inst. own
85.48%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
18.87
200-d avg
15.13
1y target
49.50

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for BIOA has not been loaded yet. Try again in a moment.

Analyst view

Price target (mean) 49.50 +746.2% upside
Target (low)
23.00
Target (mean)
49.50
Target (high)
73.00
Ratings (0m) 9 7 buy · 2 hold · 0 sell
  • Strong buy2
  • Buy5
  • Hold2
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 9
  • 1 month ago 9
  • 2 months ago 7

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

BIOA analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.63167-0.75 – -0.54-0.60-5.3%1.58M-34.3%6
Next quarter-0.65612-0.85 – -0.53-0.56-17.2%1.54M-25.0%6
Current year-2.49-3.03 – -2.12-2.24-11.3%54.29M+503.6%7
Next year-2.06-3.02 – 1.15-2.49+17.3%35.42M-34.8%7

Upgrades and downgrades

The latest rating changes

BIOA analyst upgrades and downgrades
DateFirmActionFromTo
May 27, 2026Roth CapitalInitiated—Buy
May 13, 2026BTIGInitiated—Buy
Mar 27, 2026NeedhamInitiated—Buy
Mar 10, 2026CitigroupMaintainedBuyBuy
Feb 25, 2026OppenheimerInitiated—Outperform
Feb 18, 2026JefferiesUpgradeHoldBuy
Jan 27, 2026Piper SandlerInitiated—Overweight
Dec 8, 2025Morgan StanleyUpgradeUnderweightEqual-Weight
Oct 29, 2025CitigroupMaintainedBuyBuy
Oct 22, 2025CitigroupUpgradeNeutralBuy
Mar 24, 2025CitigroupMaintainedNeutralNeutral
Feb 28, 2025William BlairInitiated—Market Perform
Dec 9, 2024CitigroupDowngradeBuyNeutral
Dec 9, 2024JefferiesDowngradeBuyHold